Voloridge Investment Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.98M | Sell |
789,506
-270,649
| -26% | -$1.36M | 0.01% | 810 |
|
2025
Q1 | $6.87M | Buy |
1,060,155
+290,430
| +38% | +$1.88M | 0.03% | 691 |
|
2024
Q4 | $5.65M | Sell |
769,725
-205,575
| -21% | -$1.51M | 0.02% | 745 |
|
2024
Q3 | $7.3M | Sell |
975,300
-249,598
| -20% | -$1.87M | 0.03% | 680 |
|
2024
Q2 | $10.9M | Buy |
1,224,898
+521,370
| +74% | +$4.64M | 0.04% | 543 |
|
2024
Q1 | $7.13M | Buy |
703,528
+149,722
| +27% | +$1.52M | 0.03% | 566 |
|
2023
Q4 | $5.57M | Buy |
553,806
+113,038
| +26% | +$1.14M | 0.02% | 593 |
|
2023
Q3 | $4.13M | Buy |
+440,768
| New | +$4.13M | 0.02% | 716 |
|
2022
Q1 | – | Sell |
-355,091
| Closed | -$14.9M | – | 1721 |
|
2021
Q4 | $14.9M | Buy |
355,091
+153,578
| +76% | +$6.43M | 0.08% | 350 |
|
2021
Q3 | $8.77M | Sell |
201,513
-6,656
| -3% | -$290K | 0.06% | 475 |
|
2021
Q2 | $9.84M | Sell |
208,169
-75,600
| -27% | -$3.57M | 0.07% | 416 |
|
2021
Q1 | $14.5M | Sell |
283,769
-67,356
| -19% | -$3.45M | 0.11% | 259 |
|
2020
Q4 | $9.4M | Buy |
+351,125
| New | +$9.4M | 0.08% | 283 |
|